Initiative / BiomarCaRE

Biomarker for Cardiovascular Risk Assessment across Europe

Biomarker for Cardiovascular Risk Assessment across Europe

BiomarCaRE logo
Studies 0
The objective of BiomarCaRE is to assess the value of established and emerging biomarkers for cardiovascular risk prediction.
Visit BiomarCaRE

Members

Investigators Contacts
  • Tanja Zeller
    University Medical Center Hamburg-Eppendorf (UKE)
  • Stefan Blankenberg
    University Medical Center Hamburg-Eppendorf (UKE)

General Information

Year created
2011
Types of cohorts
  • Population cohort
  • Patient/disease cohort
  • Clinical trial
Region
Europe, Australia, Israel, Latin America, New Zeland, South Africa, United States of America.
Setting
International
Funding
The BiomarCaRE project was co-funded by the European Community´s Seventh Framework Programme (FP7/2007-2013) under grant agreement N° HEALTH-F2-2011-278913.
Criteria of cohort's to be included
Disease cohorts: individuals with either angiographically proven stable coronary artery disease, mostly after myocardial infarction, or individuals presenting with suspected acute coronary syndrome. Clinical trials: subjects with coronary heart disease with or without acute coronary syndrome; subjects 50 years old who did not have preexisting cardiovascular disease or diabetes, and had a low-density lipoprotein cholesterol < 130 mg/dL and C-reactive protein ≥ 2.0 mg/L.
Socio-environmental context
  • Environmental hazards
  • Urbanization

Participants

Number of participants

Total
300,000

Age range of the samples

Minimum age
18
Maximum age
150

Methodology for harmonization and integration

Strategy of harmonization
Ex-post
Data processing methods
  • NA
  • Integrative data analysis
    • Pooled analyses
    Software
  • NA
  • Number of cohorts

    Total
    31
    With harmonized data
    5
    Will more cohorts be harmonized?

    Access

    Availability of metadata
    Availability of individual data